Bacterial membrane vesicles for vaccine applications

Summary

This review examines bacterial membrane vesicles as adaptable vaccine platforms for diseases that still lack effective approved vaccines. It frames the field around recurring formulation problems shared by otherwise different infectious and noncommunicable conditions, then synthesizes how vesicle biology may address them. Bacterial membrane vesicles are naturally immunostimulatory, can engage innate as well as adaptive immunity, and have a nanoscale form that supports uptake and processing by immune cells. The review further emphasizes their engineering flexibility: genetic modification, cargo incorporation, and nanoparticle coating can add functions or tailor the antigenic and immunological profile. Rather than reporting a single experiment, the article surveys interactions between these vesicles and immune cells and organizes applications across bacterial infection, viral infection, and cancer vaccination. Its central significance is that one biologically derived carrier may combine antigen presentation, adjuvant-like stimulation, and modular engineering within the same construct. This makes the platform relevant to several common vaccine-development bottlenecks while retaining the possibility of disease-specific customization. The abstract presents a field overview, not comparative evidence that any particular vesicle formulation is clinically superior.